nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PLA2G2A—Glycerophospholipid Biosynthetic Pathway—CHKB—narcolepsy	0.0547	0.0963	CbGpPWpGaD
Diclofenac—ASIC1—forebrain—narcolepsy	0.0308	0.0713	CbGeAlD
Diclofenac—KCNQ3—forebrain—narcolepsy	0.0245	0.0567	CbGeAlD
Diclofenac—KCNQ2—brainstem—narcolepsy	0.0234	0.0541	CbGeAlD
Diclofenac—KCNQ2—forebrain—narcolepsy	0.0226	0.0522	CbGeAlD
Diclofenac—ASIC1—medulla oblongata—narcolepsy	0.0223	0.0515	CbGeAlD
Diclofenac—ASIC1—midbrain—narcolepsy	0.0203	0.0471	CbGeAlD
Diclofenac—CXCR1—GPCRs, Other—P2RY11—narcolepsy	0.0184	0.0324	CbGpPWpGaD
Diclofenac—KCNQ3—medulla oblongata—narcolepsy	0.0177	0.041	CbGeAlD
Diclofenac—TTR—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.0177	0.0312	CbGpPWpGaD
Diclofenac—PLA2G2A—Glycerophospholipid biosynthesis—CHKB—narcolepsy	0.0174	0.0306	CbGpPWpGaD
Diclofenac—KCNQ3—midbrain—narcolepsy	0.0162	0.0375	CbGeAlD
Diclofenac—SLCO1C1—forebrain—narcolepsy	0.0157	0.0363	CbGeAlD
Diclofenac—TTR—brainstem—narcolepsy	0.0145	0.0336	CbGeAlD
Diclofenac—TTR—forebrain—narcolepsy	0.014	0.0325	CbGeAlD
Diclofenac—CXCL8—medulla oblongata—narcolepsy	0.0133	0.0308	CbGeAlD
Diclofenac—ASIC1—brain—narcolepsy	0.0128	0.0296	CbGeAlD
Diclofenac—PLA2G2A—midbrain—narcolepsy	0.0123	0.0284	CbGeAlD
Diclofenac—CXCL8—midbrain—narcolepsy	0.0121	0.0281	CbGeAlD
Diclofenac—PLA2G2A—Phospholipid metabolism—CHKB—narcolepsy	0.0121	0.0214	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0106	0.0186	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0106	0.0186	CbGpPWpGaD
Diclofenac—SLCO1C1—midbrain—narcolepsy	0.0104	0.024	CbGeAlD
Diclofenac—KCNQ3—brain—narcolepsy	0.0102	0.0235	CbGeAlD
Diclofenac—TTR—medulla oblongata—narcolepsy	0.0101	0.0235	CbGeAlD
Diclofenac—KCNQ2—brain—narcolepsy	0.00936	0.0217	CbGeAlD
Diclofenac—TTR—midbrain—narcolepsy	0.00926	0.0214	CbGeAlD
Diclofenac—CXCR1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00868	0.0153	CbGpPWpGaD
Diclofenac—ABCC4—forebrain—narcolepsy	0.00866	0.0201	CbGeAlD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00828	0.0146	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00828	0.0146	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00799	0.0141	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—PENK—narcolepsy	0.00776	0.0137	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00774	0.0136	CbGpPWpGaD
Diclofenac—PLA2G2A—brain—narcolepsy	0.00771	0.0178	CbGeAlD
Diclofenac—CXCL8—brain—narcolepsy	0.00763	0.0177	CbGeAlD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00709	0.0125	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00709	0.0125	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00685	0.0121	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00658	0.0116	CbGpPWpGaD
Diclofenac—CXCR1—G alpha (i) signalling events—PENK—narcolepsy	0.00653	0.0115	CbGpPWpGaD
Diclofenac—SLCO1C1—brain—narcolepsy	0.00651	0.0151	CbGeAlD
Diclofenac—ABCC4—Ectoderm Differentiation—SOCS2—narcolepsy	0.00615	0.0108	CbGpPWpGaD
Diclofenac—SCN4A—brain—narcolepsy	0.00598	0.0138	CbGeAlD
Diclofenac—SLC22A6—brain—narcolepsy	0.00596	0.0138	CbGeAlD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00582	0.0103	CbGpPWpGaD
Diclofenac—TTR—brain—narcolepsy	0.00582	0.0135	CbGeAlD
Diclofenac—CXCR1—GPCR ligand binding—HCRTR1—narcolepsy	0.0054	0.00951	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—HCRTR2—narcolepsy	0.0054	0.00951	CbGpPWpGaD
Diclofenac—ALOX5—brain—narcolepsy	0.00527	0.0122	CbGeAlD
Diclofenac—CXCR1—GPCR ligand binding—P2RY11—narcolepsy	0.00522	0.00918	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00519	0.00914	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Other—HTR2A—narcolepsy	0.00518	0.00912	CbGpPWpGaD
Diclofenac—PTGS1—forebrain—narcolepsy	0.0051	0.0118	CbGeAlD
Diclofenac—PTGS2—forebrain—narcolepsy	0.00487	0.0113	CbGeAlD
Diclofenac—CXCR1—G alpha (i) signalling events—HRH3—narcolepsy	0.00487	0.00857	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00478	0.00841	CbGpPWpGaD
Diclofenac—CXCR1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00478	0.00841	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.00477	0.0084	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.00477	0.0084	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00452	0.00795	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—HCRT—narcolepsy	0.00443	0.00781	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00441	0.00777	CbGpPWpGaD
Diclofenac—ALB—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.00421	0.00741	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—PENK—narcolepsy	0.00395	0.00696	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00392	0.0069	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00391	0.00688	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00387	0.00681	CbGpPWpGaD
Diclofenac—CYP2E1—medulla oblongata—narcolepsy	0.00382	0.00886	CbGeAlD
Diclofenac—ALB—brain—narcolepsy	0.00371	0.0086	CbGeAlD
Diclofenac—ABCC4—brain—narcolepsy	0.00359	0.00832	CbGeAlD
Diclofenac—SLC22A8—brain—narcolepsy	0.00357	0.00826	CbGeAlD
Diclofenac—CXCL8—Overview of nanoparticle effects—TNF—narcolepsy	0.00352	0.0062	CbGpPWpGaD
Diclofenac—PTGS2—medulla oblongata—narcolepsy	0.00352	0.00815	CbGeAlD
Diclofenac—CXCL8—Peptide ligand-binding receptors—PENK—narcolepsy	0.00349	0.00615	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—TRH—narcolepsy	0.00336	0.00592	CbGpPWpGaD
Diclofenac—CXCL8—Allograft Rejection—HLA-DQA1—narcolepsy	0.00335	0.0059	CbGpPWpGaD
Diclofenac—PTGS2—midbrain—narcolepsy	0.00322	0.00745	CbGeAlD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00321	0.00564	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00321	0.00564	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0032	0.00563	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0032	0.00563	CbGpPWpGaD
Diclofenac—CXCL8—Allograft Rejection—HLA-DQB1—narcolepsy	0.00313	0.00552	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00309	0.00544	CbGpPWpGaD
Diclofenac—ABCC1—brain—narcolepsy	0.00306	0.0071	CbGeAlD
Diclofenac—CXCR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00305	0.00537	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00305	0.00537	CbGpPWpGaD
Diclofenac—CXCL8—EBV LMP1 signaling—TNF—narcolepsy	0.00302	0.00532	CbGpPWpGaD
Diclofenac—ABCB1—forebrain—narcolepsy	0.00302	0.00698	CbGeAlD
Diclofenac—CXCL8—Peptide ligand-binding receptors—TRH—narcolepsy	0.00297	0.00523	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00295	0.00519	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—HRH3—narcolepsy	0.00295	0.00519	CbGpPWpGaD
Diclofenac—CXCL8—G alpha (i) signalling events—PENK—narcolepsy	0.00295	0.00519	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00287	0.00505	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00277	0.00488	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00277	0.00488	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—P2RY11—narcolepsy	0.00268	0.00471	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00266	0.00468	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00263	0.00463	CbGpPWpGaD
Diclofenac—CYP2C8—brain—narcolepsy	0.00261	0.00604	CbGeAlD
Diclofenac—PLA2G2A—Cardiac Hypertrophic Response—TNF—narcolepsy	0.00261	0.00459	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00253	0.00445	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—HCRT—narcolepsy	0.00251	0.00441	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—NPS—narcolepsy	0.00244	0.0043	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—TAC1—narcolepsy	0.00244	0.0043	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—HCRTR2—narcolepsy	0.00244	0.00429	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—HCRTR1—narcolepsy	0.00244	0.00429	CbGpPWpGaD
Diclofenac—CYP1A1—brain—narcolepsy	0.00241	0.00558	CbGeAlD
Diclofenac—CXCL8—Allograft Rejection—HLA-DRB1—narcolepsy	0.00238	0.00419	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—P2RY11—narcolepsy	0.00235	0.00414	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00234	0.00412	CbGpPWpGaD
Diclofenac—CYP2B6—brain—narcolepsy	0.00234	0.00542	CbGeAlD
Diclofenac—CXCR1—Signaling by GPCR—HCRT—narcolepsy	0.00228	0.00401	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00225	0.00396	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—PENK—narcolepsy	0.00223	0.00393	CbGpPWpGaD
Diclofenac—CXCL8—G alpha (i) signalling events—HRH3—narcolepsy	0.0022	0.00387	CbGpPWpGaD
Diclofenac—CYP2E1—brain—narcolepsy	0.0022	0.00509	CbGeAlD
Diclofenac—ABCB1—medulla oblongata—narcolepsy	0.00218	0.00504	CbGeAlD
Diclofenac—CXCL8—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00216	0.0038	CbGpPWpGaD
Diclofenac—CXCL8—Peptide ligand-binding receptors—NPS—narcolepsy	0.00216	0.0038	CbGpPWpGaD
Diclofenac—PTGS1—brain—narcolepsy	0.00212	0.0049	CbGeAlD
Diclofenac—CXCR1—Signaling by GPCR—PENK—narcolepsy	0.00203	0.00357	CbGpPWpGaD
Diclofenac—PTGS2—brain—narcolepsy	0.00202	0.00468	CbGeAlD
Diclofenac—CXCL8—GPCR ligand binding—HCRT—narcolepsy	0.002	0.00352	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00199	0.00351	CbGpPWpGaD
Diclofenac—ABCB1—midbrain—narcolepsy	0.00199	0.00461	CbGeAlD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00195	0.00343	CbGpPWpGaD
Diclofenac—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.00194	0.00342	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00193	0.0034	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—TRH—narcolepsy	0.0019	0.00334	CbGpPWpGaD
Diclofenac—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.00186	0.00327	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—PENK—narcolepsy	0.00178	0.00314	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00175	0.00307	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CHKB—narcolepsy	0.00174	0.00306	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—TRH—narcolepsy	0.00172	0.00304	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—HRH3—narcolepsy	0.00167	0.00293	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HCRTR2—narcolepsy	0.00164	0.00288	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HCRTR1—narcolepsy	0.00164	0.00288	CbGpPWpGaD
Diclofenac—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.00162	0.00286	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—P2RY11—narcolepsy	0.00158	0.00278	CbGpPWpGaD
Diclofenac—PTGS2—Overview of nanoparticle effects—TNF—narcolepsy	0.00154	0.00272	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00152	0.00268	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—TRH—narcolepsy	0.00152	0.00267	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRH3—narcolepsy	0.00151	0.00266	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.0015	0.00263	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00147	0.00259	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—HTR2A—narcolepsy	0.00147	0.00259	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00145	0.00255	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00145	0.00255	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—TNF—narcolepsy	0.00142	0.00249	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—TAC1—narcolepsy	0.00138	0.00243	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—NPS—narcolepsy	0.00138	0.00243	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HCRTR2—narcolepsy	0.00138	0.00242	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HCRTR1—narcolepsy	0.00138	0.00242	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HCRT—narcolepsy	0.00134	0.00237	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—P2RY11—narcolepsy	0.00133	0.00234	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—HRH3—narcolepsy	0.00133	0.00234	CbGpPWpGaD
Diclofenac—ALOX5—Selenium Micronutrient Network—TNF—narcolepsy	0.00131	0.00231	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CHKB—narcolepsy	0.00128	0.00225	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—NPS—narcolepsy	0.00125	0.00221	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—TAC1—narcolepsy	0.00125	0.00221	CbGpPWpGaD
Diclofenac—ABCB1—brain—narcolepsy	0.00125	0.0029	CbGeAlD
Diclofenac—CXCL8—Signaling by GPCR—HCRTR1—narcolepsy	0.00125	0.0022	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HCRTR2—narcolepsy	0.00125	0.0022	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00124	0.00219	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—P2RY11—narcolepsy	0.00121	0.00213	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—PENK—narcolepsy	0.0012	0.00211	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CPT1B—narcolepsy	0.00118	0.00208	CbGpPWpGaD
Diclofenac—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00118	0.00207	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HCRT—narcolepsy	0.00113	0.00199	CbGpPWpGaD
Diclofenac—CXCL8—Allograft Rejection—TNF—narcolepsy	0.00113	0.00198	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—NPS—narcolepsy	0.0011	0.00194	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—TAC1—narcolepsy	0.0011	0.00194	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HCRTR2—narcolepsy	0.0011	0.00194	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HCRTR1—narcolepsy	0.0011	0.00194	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—P2RY11—narcolepsy	0.00106	0.00187	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00104	0.00183	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HCRT—narcolepsy	0.00103	0.00181	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TRH—narcolepsy	0.00102	0.00179	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PENK—narcolepsy	0.00101	0.00177	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.001	0.00176	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000987	0.00174	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000973	0.00171	CbGpPWpGaD
Diclofenac—CXCL8—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000918	0.00162	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PENK—narcolepsy	0.000915	0.00161	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HCRT—narcolepsy	0.000905	0.00159	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRH3—narcolepsy	0.000893	0.00157	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000876	0.00154	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000871	0.00153	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CPT1B—narcolepsy	0.000868	0.00153	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CHKB—narcolepsy	0.000859	0.00151	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—TRH—narcolepsy	0.000857	0.00151	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000845	0.00149	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CHKB—narcolepsy	0.000836	0.00147	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—HTR2A—narcolepsy	0.00083	0.00146	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—TNF—narcolepsy	0.000817	0.00144	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PENK—narcolepsy	0.000806	0.00142	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000803	0.00141	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000799	0.00141	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TRH—narcolepsy	0.000778	0.00137	CbGpPWpGaD
Diclofenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000761	0.00134	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HTR2A—narcolepsy	0.000754	0.00133	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HRH3—narcolepsy	0.000752	0.00132	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NPS—narcolepsy	0.00074	0.0013	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TAC1—narcolepsy	0.00074	0.0013	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00074	0.0013	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HCRTR1—narcolepsy	0.000739	0.0013	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HCRTR2—narcolepsy	0.000739	0.0013	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000717	0.00126	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000717	0.00126	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—P2RY11—narcolepsy	0.000714	0.00126	CbGpPWpGaD
Diclofenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000711	0.00125	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TRH—narcolepsy	0.000686	0.00121	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRH3—narcolepsy	0.000683	0.0012	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CHKB—narcolepsy	0.000679	0.0012	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000675	0.00119	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000675	0.00119	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000671	0.00118	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—HTR2A—narcolepsy	0.000663	0.00117	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CHKB—narcolepsy	0.000655	0.00115	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000654	0.00115	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000654	0.00115	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—TAC1—narcolepsy	0.000623	0.0011	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—NPS—narcolepsy	0.000623	0.0011	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HCRT—narcolepsy	0.000607	0.00107	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRH3—narcolepsy	0.000601	0.00106	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000596	0.00105	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CPT1B—narcolepsy	0.000584	0.00103	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.00057	0.001	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CPT1B—narcolepsy	0.000568	0.001	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000567	0.000997	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TAC1—narcolepsy	0.000566	0.000996	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NPS—narcolepsy	0.000566	0.000996	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000559	0.000983	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CHKB—narcolepsy	0.000554	0.000975	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000546	0.000961	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000543	0.000956	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PENK—narcolepsy	0.000541	0.000952	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TAC1—narcolepsy	0.000498	0.000877	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NPS—narcolepsy	0.000498	0.000877	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000487	0.000858	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—TNF—narcolepsy	0.000475	0.000837	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—TNF—narcolepsy	0.000475	0.000837	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CPT1B—narcolepsy	0.000462	0.000813	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TNF—narcolepsy	0.000461	0.000811	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TRH—narcolepsy	0.00046	0.000809	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—TNF—narcolepsy	0.000453	0.000797	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HTR2A—narcolepsy	0.000445	0.000784	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CPT1B—narcolepsy	0.000445	0.000784	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000444	0.000782	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CHKB—narcolepsy	0.00044	0.000774	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00043	0.000758	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00043	0.000758	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CHKB—narcolepsy	0.000423	0.000744	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CHKB—narcolepsy	0.000414	0.000729	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRH3—narcolepsy	0.000403	0.00071	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CHKB—narcolepsy	0.00039	0.000687	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00038	0.000668	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CPT1B—narcolepsy	0.000376	0.000663	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HTR2A—narcolepsy	0.000375	0.00066	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—TNF—narcolepsy	0.000366	0.000645	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TNF—narcolepsy	0.00036	0.000634	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TNF—narcolepsy	0.000358	0.00063	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CHKB—narcolepsy	0.000358	0.00063	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CHKB—narcolepsy	0.000356	0.000626	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00035	0.000616	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HTR2A—narcolepsy	0.00034	0.000599	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NPS—narcolepsy	0.000334	0.000588	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TAC1—narcolepsy	0.000334	0.000588	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CHKB—narcolepsy	0.000319	0.000562	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CHKB—narcolepsy	0.000312	0.000549	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HTR2A—narcolepsy	0.0003	0.000527	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CPT1B—narcolepsy	0.000299	0.000526	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CHKB—narcolepsy	0.000291	0.000512	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000287	0.000506	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CPT1B—narcolepsy	0.000281	0.000495	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CPT1B—narcolepsy	0.000265	0.000467	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CHKB—narcolepsy	0.000249	0.000438	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000244	0.000429	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000243	0.000428	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CPT1B—narcolepsy	0.000242	0.000426	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000217	0.000382	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CPT1B—narcolepsy	0.000212	0.000373	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HTR2A—narcolepsy	0.000201	0.000354	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000198	0.000348	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CHKB—narcolepsy	0.000192	0.000338	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000173	0.000304	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000169	0.000298	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000131	0.00023	CbGpPWpGaD
